載入...
Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes
Repaglinide, an oral hypoglycemic agent, is a short-acting insulin secretagogue. We describe a case, in which an extremely low dose of repaglinide caused severe hypoglycemia and novel drug interactions are suggested. A 71-year-old man with type 2 diabetes was taken to the hospital due to consciousne...
Na minha lista:
| 發表在: | Diabetol Int |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Singapore
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7538475/ https://ncbi.nlm.nih.gov/pubmed/33088647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-020-00434-w |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|